Small Cell Lung Cancer Presenting With a Nasal Cavity Metastasis

This lung cancer diagnosis at a glance

Subtype
Small Cell Lung Cancer
Biomarkers
CD56 positive, chromogranin positive, synaptophysin positive
Sex
male
Spread to
nasal cavity
Treatment
chemotherapy and radiation
Outcome
In Memory

Treatment course, step by step

  1. He received palliative chemoradiotherapy.
  2. The nasal cavity and chest masses showed near-total resolution after treatment.
  3. After 12 months of remission, the nasal cavity disease recurred aggressively.
  4. He declined further palliative chemotherapy.

What happened, in summary

A 58-year-old man was referred to a head and neck clinic after 4 months of persistent right-sided nasal discharge. He also had reduced smell and taste and numbness over the right upper cheek. Examination found a large ulcerated mass in the right nasal cavity. Further investigation identified small cell lung cancer as the most likely primary cancer, with metastatic spread to the nasal cavity. The tumor showed positive staining for CD56, chromogranin and synaptophysin. The patient received palliative chemoradiotherapy and initially had an excellent response, with near-total resolution of both the nasal cavity mass and the chest mass. He then remained in remission for 12 months. Follow-up imaging later showed an aggressive recurrence in the nasal cavity. Further palliative chemotherapy was offered, but he declined it. He died 2 months after the recurrence, 14 months after the original diagnosis. The nasal cavity metastasis made this an unusual presentation, because nasal symptoms were what first brought him to medical attention.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar lung cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more lung cancer stories